Keywords: AC; acetanilide; ACE; affinity capillary electrophoresis; AGP; human alpha (α1)-acid glycoprotein; BMImBr; 1-Butyl-3-methylimidazolium bromide; BMImCl; 1-butyl-3-methylimidazolium chloride; BMImBF4; 1-butyl-3-methylimidazolium tetrafluoroborate; DMImCl;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Rheumatoid arthritis; Interstitial lung diseases; High-resolution computed tomography; Survival; ANA; antinuclear antibodies; CTD; connective tissue diseases; DAD; diffuse alveolar damage; DLCO; diffusion capacity to carbon monoxide; FEV1; forced expirato
Keywords: ALL; acute lymphoblastic leukemia; AraC; cytosine Arabinoside; BrdU; bromodeoxyuridine; CNS; central nervous system; DG; Dorsal Ganglion; DHFR; dihydrofolate reductase; IP; intraperitoneal; LSD; Fisher's least significant difference; MTX; methotrexate;
Keywords: Rheumatoid arthritis; Inflammation; Methotrexate; Prodrug; Thiazolidinone; Reactive oxygen species; ADMET; absorption, distribution, metabolism, excretion, toxicity; CFA; Complete Freund's Adjuvant; CIA; collagen-induced arthritis; CL'int; apparent intrin
Keywords: AZA; azathioprine; ADA; adalimumab; CYA; cyclosporine A; CYX; cyclophosphamide; ETN; etanercept; FK; tacrolimus; IFX; infliximab; IS; immunosuppressant; LFM; leflunomide; MMF; mycophenolate mofetil; MTX; methotrexate; RTX; rituximab; TAK; Takayasu's Arter
Keywords: RA; rheumatoid arthritis; RCT; randomized controlled trial; DMARDs; Non-biologic Disease-Modifying Anti-Rheumatic Drugs; HDL; high-density lipoprotein; LDL; low-density lipoprotein; ESR; erythrocyte sedimentation rate; CRP; C-reactive protein; TG; triglyc
Keywords: MS; multiple sclerosis; MS-RR; relapsing-remitting multiple sclerosis; MS-SP; secondary progressive multiple sclerosis; MS-PP; primary progressive multiple sclerosis; IFN-Ã; interferon-beta; GA; glatiramer acetate; DMT; disease-modifying treatment; CIS;
Keywords: physical signs; pathophysiology; treatment; BMT; Bone marrow transplantation; CyA; Cyclosporine A; HCQ; Hydroxychloroquine; HLA; Human leukocyte antigen; IL; Interleukin; IVIG; Intravenous immunoglobulin therapy; JDM; Juvenile dermatomyositis; JM; Juvenil
Keywords: Zinc phthalocyanine; Phospholipid complex; Synergetic therapy; Photoacoustic image; Fluorescence image; Photothermal treatment; Photodynamic treatment; Folate receptor-targeted; Zinc phthalocyanine; ZnPc; Doxorubicin; Dox; Photothermal therapy; PTT; Photo
Keywords: ACPA; anti-citrullinated protein antibody; AP; recombinant human placental alkaline phosphatase = hRESCAP® (human rescue alkaline phosphatase); DAS; disease activity score; DMARD; disease modifying anti-rheumatic drug; EULAR; European league against rheu
Keywords: Active Ulcerative Colitis; IBD Therapy; Immunosuppressive Agent; Inflammatory Bowel Diseases; AE; adverse event; CD; Crohn's disease; FCP; fecal calprotectin; IBD; inflammatory bowel disease; MERIT-UC; Methotrexate Response in Treatment of Ulcerative Co
Keywords: RA; rheumatoid arthritis; TCZ; tocilizumab; TOFA; tofacitinib citrate; MTX; methotrexate; DMARD; disease-modifying antirheumatic drug; bDMARD; biologic disease-modifying antirheumatic drug; nbDMARD; non-biologic disease-modifying antirheumatic drug; obDMA
Keywords: Biologics; Inflammatory Bowel Disease; Crohn's Disease; Ulcerative Colitis; AEs; adverse events; CD; Crohn's disease; DMARDs; disease-modifying antirheumatic drug; IBD; inflammatory bowel disease; MTX; methotrexate; RA; rheumatoid arthritis; RTX; rit
Keywords: ACV; acyclovir; MTX; methotrexate; [EMIM][OAc]; 1-ethyl-3-methylimidazolium acetate; [DEA][OAc]; diethylammonium acetate; [TEA][OAc]; triethylammonium acetate; TDD; transdermal delivery; IL/O; ionic liquid in oil; IL/W; ionic liquid in water; O/IL; oil in
Keywords: Carbon nanocomposite; Fluorescent imaging probe; Fluorescent spectroscopy; Artificial neural networks; ANN; artificial neural network; Cop; copolymer; DLS; dynamic light scattering; FA; folic acid; FRα; alpha receptors for folic acid; MLP; multilayer per
Keywords: HSA-MTX; human serum albumin-methotrexate conjugates; MTX; methotrexate; MTX-PGA; methotrexate-conjugated poly(glycerol adipate); PCE; porcine carboxylesterase enzyme; PDC; polymer-drug conjugates; PGA; poly(glycerol adipate); Poly(glycerol adipate); Meth
Keywords: DOX; Doxorubicin; MTX; Methotrexate; Cs; Chitosan; mPEG; Methoxypolyethylene glycol; EPR; Enhanced Permeability and Retention; DDS; Drug Delivery System; HRBCs; Human Red Blood Cells; HBP; Human Blood Plasma; Combination chemotherapy; Multi-branched chito
Keywords: Nanohybrids; Proteins; Polysaccharides; Drug delivery; Electrostatic nanocomplexes; Maillard conjugates; Electrospinning; 5-FU; 5-Fluorouracil; α-La; α-lactalbumin; β-Lg; β-lactoglobulin; BSA; Bovine serum albumin; CMC; Carboxymethyl cellulose; CMCS;
Keywords: 5-FU; 5-fluouracil; CAL; Conditional associative learning; CICI; chemotherapy-induced cognitive impairment; CON; Control; DCX; doublecortin; Gd-DTPA; gadopentetic acid; MTX; methotrexate; NMTS; non-matching-to-sample; PBS; phosphate-buffered saline; PFA;
Keywords: ABC; ATP-Binding cassette; ARPE-19; human retinal pigment epithelial cells; BBB; blood-brain barrier; BCRP; breast cancer resistant protein; CNS; central nervous system; 3D-QSAR; 3-Dimensional Quantitative Structure Activity; ELC; elacridar; LAT1; l-Type
Keywords: UNITI Trials; Inflammatory Bowel Disease Treatment; IBD; Anti-IL12/23; 6-MP; 6-mercaptopurine; AUC; area under the curve; AZA; azathioprine; CD; Crohn's disease; CDAI; Crohn's Disease Activity Index; CRP; Creactive protein; ECLIA; electrochemilumines
Keywords: AICA; 5-aminoimidazole-4-carboxamide; AICARFTase; 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase; CA; carbonic anhydrase; CBE; CI-HCO3â exchanger; CHO; Chinese hamster ovary; FR; folate receptor; GARFTase; β-glycinamide ribonucleotide
Keywords: MDR; multi-drug resistance; PPI; polypropyleneimine; RBC; red blood cell; WBC; white blood cell; LDH; lactate dehydrogenase; EPR; enhances permeability and retention; FA; folic acid; FR; FA receptor; SMUT; sodium-dependent multi-vitamin transporter; FITC;
Keywords: Drug delivery; Lipid carrier; Nanotechnology; Nanocarrier; Controlled release; NEMS; Nano electromechanical systems; MEMS; Micro-electromechanical systems; NE; Nanoemulsions; NPs; Nanoparticles; QD; Quantum dots; PLA; Polylactic acid; PGA; Polyglycolic ac
Keywords: CT; computed tomography; EFS; event-free survival; OS; overall survival; MRI; magnetic resonance imaging; MTX; methotrexate; TACE; transcatheter arterial chemoembolization; TNF-α; tumor necrosis factor alpha; VAC; vincristine and actinomycin-D with or wi
Keywords: Eccentric IUP; angular pregnancy; interstitial EP; ultrasound; β-hCG; beta human chorionic gonadotropin; EP; ectopic pregnancy; GS; gestational sac; IUP; intrauterine pregnancy; MTX; methotrexate; SE; surrounding endometrium; US; ultrasound;
Keywords: PPV23; pneumococcal polysaccharide vaccine; PCV7; pneumococcal conjugate vaccine; IPD; invasive pneumococcal disease; ANCA; antineutrophil cytoplasmic antibody; PR3-ANCA; ANCA directed against proteinase 3; MPO-ANCA; ANCA directed against myeloperoxidase;
Keywords: uveitis; pediatric; epidemiology; steroid sparing; biologic agents; AZA; Azathioprine; CS; Corticosteroids; DMARDs; Disease-modifying antirheumatic drugs; JIA; Juvenile idiopathic arthritis; MTX; Methotrexate; SUN; Standardization of Uveitis Nomenclature;
Keywords: Caesarean scar pregnancy; type 1 Caesarean scar pregnancy; type 2 Caesarean scar pregnancy; surgical management; algorithm; β-hCG; beta human chorionic gonadotropin; CSP; Caesarean scar pregnancy; LUS; lower uterine segment; MTX; methotrexate; PRBC; pack
Keywords: TriZol Reagent; buffered 10% formalin; ethanol; xylol; paraffin; hematoxylin and eosin (HE); phosphate buffer (pH 6.5); Griess solution (0.1% N-1-naphthyl-tilediamine, 1% sulfanilamide in 5% H3PO4); saline Triton X-100 0.1%, TMB 18.4âmM; dimethylformami
Keywords: Cytokines; Signal transduction; Drug development; Inflammation; Autoimmunity; Therapy; JAK; Janus Kinase; STAT; Signal transducer and activator of transcription; NF-kB; nuclear factor kappa-light-chain-enhancer of activated B cells; MAPK; Mitogen activate
Keywords: Multistage nanoparticles; PAMAM dendrimers; MMP-2 enzyme; Tumor microenvironment responsive; NPs; nanoparticles; MTX; methotrexate; PAMAM; polyamidoamine; MMP-2; matrix metalloproteinase-2;
Keywords: Antioxidants; MTX; Hepatotoxicity; ROS; Apoptosis;
Keywords: ACR; American College of Rheumatology; ALT; alanine aminotransferase; ANA; anti-nuclear antibodies; anti-CCP; anti-cyclic citrullinated antibodies; anti-TG; anti-thyroglobulin antibody; AST; aspartate aminotransferase; bDMARD; biologic disease modifying a
Keywords: ACPA; anti-citrullinated protein antibody; ACR; American College of Rheumatology; bDMARD; biologic disease-modifying antirheumatic drug; BMI; body mass index; CRP; C-reactive protein; csDMARD; conventional synthetic disease-modifying antirheumatic drug; C
Keywords: ADA; antidrug antibody; AGA; American Gastroenterological Association; Anti-TNF; anti-tumor necrosis factor; AZA; azathioprine; CD; Crohn disease; CTE; computed tomography enterography; EIM; extraintestinal manifestation; FDA; Food and Drug Administrati
Keywords: Folate pathway; Trypanosomatids; Structure-based drug design; Selective inhibition; Enzyme inhibitor; Anti-parasitic drug; PTR1; Pteridine reductase 1; DHFR; Dihydrofolate reductase; dUMP; Deoxyuridine monophosphate; dTMP; Deoxythymidine monophosphate; hD
Keywords: MTX; methotrexate; TNF; tumor necrosis factor; IL; interleukin; CTLA4; cytotoxic T-lymphocyte antigen 4; IFX; infliximab; ADA; adalimumab; GLM; golimumab; CZP; certolizumab pegol; ETN; etanercept; TCZ; tocilizumab; ABA; abatacept; RTX; rituximab; UTK; ust
Keywords: ADA; adalimumab; AEs; adverse events; AZA; azathioprine; CI; confidence interval; Cy; cyclosporine; CNS; central nervous system; CS; corticosteroids; CYC; cyclophosphamide; CZP; certolizumab pegol; ePOST; Extrapulmonary Physician Organ Severity Tool; ETN;
Keywords: nGO; nano graphene oxide; DA; dopamine; MTX; Methotrexate; EPR; enhanced permeation and retention; EDC; N-(3-dimethylaminopropyl-N-ethylcarbodiimide) hydrochloride; NHS; N-hydroxysuccinimide; FT-IR; Fourier transform infrared; AFM; atomic force microscopy
Keywords: DAS28-CRP; Disease Activity Score from measures of 28 joints and C-reactive protein; IFN-α; Interferon alpha; IL-1b; Interleukin-1b, IL-6, Interleukine-6; sIL-6R; soluble interleukin-6 receptor; MCD; multicentric Castleman's disease; MCD-SS; Multicentr
Keywords: AD; atopic dermatitis; α2HS-GP; alpha-2-HS-glycoprotein; CCL20; C-C motif ligand 20; CCR2; C-C chemokine receptor type 2; CRP; C-reactive protein; CYA; ciclosporin; DC; dendritic cells; Dkk-1; dickkopf-related protein 1; dMVECs; dermal microvascular
Keywords: ACL; Aceclofenac; AUC; area under the curve; BBB; blood-brain barrier; BCS; Biopharmaceutical classification system; BVC; bupivacaine; CNS; central nervous system; CUR; Curcumin; DMBA; 7,12-dimethylbenzanthracene; DOX; doxorubicin; DSPE-PEG2000; 1,2-diste
Keywords: Bone morphogenetic protein-7 (BMP-7); Chinese hamster ovary (CHO) cells; Recombinant protein expression; Stable cell line; Bioreactor process; BMP-7; bone morphogenetic protein-7; CHO; Chinese hamster ovary; DHFR; dihydrofolate reductase; EC50; effective
Keywords: children; fatal outcome; febrile ulceronecrotic Mucha-Habermann disease; ABS; antibiotics; DDS; diamino-diphenyl sulphone; FUMHD; Febrile ulceronecrotic Mucha-Habermann disease; IVIG; intravenous immunoglobulins; MI; mucosal involvement; MTX; methotrexate
Keywords: AE; adverse event; ACR; American College of Rheumatology; Apo; apolipoprotein; BID; twice daily; BP; blood pressure; CHF; congestive heart failure; CRP; C-reactive protein; csDMARD; conventional synthetic disease-modifying antirheumatic drug; CV; cardiova
Keywords: MTX; methotrexate; F; fucose; G; gaalactose; M; mannose; NPs; nanoparticles; EPR; enhanced permeation and retention; PL S100; Phospholipon S100; PCL; polycaprolactone; C-6; coumarin-6; DMF; dimethyl formamide; DCM; dichloromethane; PDI; Polydispersity Ind
Keywords: ACPP; activated cell-penetrating peptide; AFM; atomic force microscopy; AN; angiopeptin; ANP; NP modified with ACPP peptide; APE-1; apurinic endonuclease-1; AU; gold; AUC; area under the curve; AUNP; gold nanoparticles; AUNS; gold nanoshells; BAT; brain a
Keywords: ADH; adipic acid dihydrazide; AUNPs; gold nanoparticles; BA; butyric acid; CDDP; cisplatin; CHI; chitosane; CNTs; carbon nanotubes; CPT; camptothecin; CSCs; cancer stem cells; DiPhPE; diphytanoyl-sn-glycero-3-glycerophosphatidyl ethanolamine; DL; drug loa
Keywords: 3D; three-dimensional; ACA; alkylcyanoacrylates; AETMAC; 2-acryloxyethyltrimethylammonium chloride; ATRP; atom transfer radical polymerization; AuNPs; gold nanoparticles; bFGF; basic fibroblast growth factor; BM-MSCs; bone marrow-derived mesenchymal stem